Tofidence Injection
Product Images NDC 64406-024

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tofidence (NDC 64406-024). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biogen Ma Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Tof02 0000 01)

A line graph illustrating mean serum concentration levels over time for Tocilizumab at different dosages or formulations, with error bars representing variability. The x-axis shows time intervals, and the y-axis represents serum concentration (units not specified). Two distinct curves indicate comparison data points in the study.*

FDA Label Image

Figure 2 (Tof02 0000 02)

A forest plot chart showing risk difference percentages for multiple studies comparing two treatments, with each study represented by a horizontal line and a dot indicating point estimates. The plot includes confidence intervals and an overall summary estimate at the bottom. The chart labels include study names, sample sizes (SOC and Tocilizumab + SOC), and risk difference percentages with confidence intervals.*

FDA Label Image

Principal Display Panel (200 mg/10 mL Vial Carton)

Label for Tofidence (tocilizumab-bavi) injection, 200 mg/10 mL (20 mg/mL) intravenous infusion after dilution, manufactured by Biogen MA Inc. The label includes dosage strength, route, single-dose vial instructions, storage conditions, and manufacturer contact information. The packaging features the Biogen logo and a barcode.*

FDA Label Image

Principal Display Panel (400 mg/20 mL Vial Carton)

Tofidence (tocilizumab-bavi) Injection 400 mg/20 mL (20 mg/mL) intravenous infusion for injection in a single-dose vial. The packaging label includes storage instructions to refrigerate at 2°C to 8°C, and warnings to protect from light and not to freeze. Manufactured by Biogen MA Inc. in Cambridge, MA, with the country of origin listed as China.*

FDA Label Image

Principal Display Panel (80 mg/4 mL Vial Carton)

The carton label for Tofidence (tocilizumab-bavi) Injection displays the strength as 80 mg/4 mL (20 mg/mL). It indicates the product is for intravenous infusion after dilution and is supplied as a single-dose vial. The label includes storage instructions (refrigeration at 2°C to 8°C) and states no preservative is present. Manufactured by Biogen MA Inc., Cambridge, MA, the label also shows the NDC number 64406-024-01 and includes barcode and QR code images.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.